Literature DB >> 20045038

Regulation of neural stem/progenitor cell maintenance by PI3K and mTOR.

Atsushi Sato1, Jun Sunayama, Ken-ichiro Matsuda, Ken Tachibana, Kaori Sakurada, Arata Tomiyama, Takamasa Kayama, Chifumi Kitanaka.   

Abstract

Control of stem cell state and differentiation of neural stem/progenitor cells is essential for proper development of the nervous system. EGF and FGF2 play important roles in the control of neural stem/progenitor cells, but the underlying mechanism still remains unclear. Here we show, using in vitro primary cultures of mouse neural stem/progenitor cells, that both PI3K and mTOR are activated by EGF/FGF2 but that inhibiting the activation of either PI3K or mTOR alone results in only reduced proliferation of neural stem/progenitor cells without affecting their stem cell state, namely, the capacity to self-renew. However, significantly, concurrent inhibition of PI3K and mTOR promoted exit from the stem cell state together with astrocytic differentiation of neural stem/progenitor cells. These findings suggest that PI3K and mTOR are involved in the EGF/FGF2-mediated maintenance of neural stem/progenitor cells and that they may act in parallel and independent pathways, complementing and backing up each other to maintain the stem cell state. (c) 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20045038     DOI: 10.1016/j.neulet.2009.12.067

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  39 in total

Review 1.  Stem cell guidance through the mechanistic target of rapamycin.

Authors:  Kenneth Maiese
Journal:  World J Stem Cells       Date:  2015-08-26       Impact factor: 5.326

Review 2.  miRNAs stem cell reprogramming for neuronal induction and differentiation.

Authors:  Claire Perruisseau-Carrier; Marcin Jurga; Nico Forraz; Colin P McGuckin
Journal:  Mol Neurobiol       Date:  2011-03-29       Impact factor: 5.590

3.  Glioma-initiating cells retain their tumorigenicity through integration of the Sox axis and Oct4 protein.

Authors:  Hiroaki Ikushima; Tomoki Todo; Yasushi Ino; Masamichi Takahashi; Nobuhito Saito; Keiji Miyazawa; Kohei Miyazono
Journal:  J Biol Chem       Date:  2011-10-10       Impact factor: 5.157

Review 4.  Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.

Authors:  Kenneth Maiese
Journal:  Br J Clin Pharmacol       Date:  2015-12-26       Impact factor: 4.335

5.  S6K Promotes Dopaminergic Neuronal Differentiation Through PI3K/Akt/mTOR-Dependent Signaling Pathways in Human Neural Stem Cells.

Authors:  Jeong Eun Lee; Mi Sun Lim; Jae Hyun Park; Chang Hwan Park; Hyun Chul Koh
Journal:  Mol Neurobiol       Date:  2015-07-05       Impact factor: 5.590

6.  MTOR signaling is essential for the development of thymic epithelial cells and the induction of central immune tolerance.

Authors:  Zhanfeng Liang; Lianjun Zhang; Huiting Su; Rong Luan; Ning Na; Lina Sun; Yang Zhao; Xiaodong Zhang; Qian Zhang; Juan Li; Lianfeng Zhang; Yong Zhao
Journal:  Autophagy       Date:  2018-01-29       Impact factor: 16.016

7.  Induced neural progenitor cells abundantly secrete extracellular vesicles and promote the proliferation of neural progenitors via extracellular signal-regulated kinase pathways.

Authors:  Yizhao Ma; Kaizhe Wang; Jiabin Pan; Zhaohuan Fan; Changhai Tian; Xiaobei Deng; Kangmu Ma; Xiaohuan Xia; Yunlong Huang; Jialin C Zheng
Journal:  Neurobiol Dis       Date:  2018-12-04       Impact factor: 5.996

Review 8.  Frontier of epilepsy research - mTOR signaling pathway.

Authors:  Chang Hoon Cho
Journal:  Exp Mol Med       Date:  2011-05-31       Impact factor: 8.718

9.  The early activation of PI3K strongly enhances the resistance of cortical neurons to hypoxic injury via the activation of downstream targets of the PI3K pathway and the normalization of the levels of PARP activity, ATP, and NAD⁺.

Authors:  Min Young Noh; Young Seo Kim; Kyu-Yong Lee; Young Joo Lee; Seung H Kim; Hyun-Jeung Yu; Seong-Ho Koh
Journal:  Mol Neurobiol       Date:  2012-12-20       Impact factor: 5.590

Review 10.  Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin.

Authors:  Zhao Zhong Chong; Yan Chen Shang; Shaohui Wang; Kenneth Maiese
Journal:  Prog Neurobiol       Date:  2012-08-15       Impact factor: 11.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.